Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
수요일, 9월 02

Alignment Healthcare Inc

ALHCNASDAQ
Trade with Public
Trade with Public
$13.59
0.191.42%
가까이에: Aug 31, 5:00 PM EST
$13.39
-0.01-0.07%
프리마켓: 4:00 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Alignment Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alignment Healthcare (ALHC).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

10Buy
1Hold
Consensus RatingOverweight# Analysts11Avg. Consensus PT$20Upside to Avg. PT+48.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026JP MorganJohn StanselPT CutOverweight$26→$22
Aug 3, 2026Raymond JamesJohn RansomDowngradeStrong Buy→Outperform$22→$19
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $26 to $22.
Benzinga Newsdesk

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $21 to $22.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and raises the price target from $18 to $19.
Benzinga Newsdesk

6 Analysts Have This To Say About Alignment Healthcare

Benzinga Insights

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and raises the price target from $23 to $26.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved